Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kyprolis
Kyprolis
Amgen launches Kyprolis in the UK for multiple myeloma
BioPharma Dive
Thu, 02/18/16 - 05:48 pm
Amgen
Kyprolis
UK
Multiple Myeloma
FDA gives full approval to Amgen blood cancer drug
Yahoo/Reuters
Thu, 01/21/16 - 06:18 pm
FDA
Amgen
Kyprolis
blood cancer
Here’s Why Amgen Shares are Likely to Rise this Year
Bidness, ETC
Tue, 01/5/16 - 03:05 pm
Amgen
R&D
Repatha
Kyprolis
The 3 Most Important Drugs in Amgen's Pipeline
Motley Fool
Fri, 12/4/15 - 08:17 pm
Amgen
ABP 501
Omecamtiv Mecarbil
Kyprolis
5 Key Drugs That Just Won EU Endorsements
Investors.com
Sat, 09/26/15 - 09:29 am
Europe
Gilead Sciences
Genvoya
Amgen
Kyprolis
Blincyto
Vertex Pharmaceuticals
Orkambi
Horizon Pharma
Ravicti
FDA Grants Priority Review for Amgen's Supplemental New Drug Application for Expanded Labeling of Kyprolis® (Carfilzomib) in Relapsed Multiple Myeloma
Yahoo
Fri, 09/18/15 - 09:17 pm
FDA
Kyprolis
Amgen
Multiple Myeloma
J&J positions blockbuster contender daratumumab for a multiple myeloma showdown
Fierce Biotech
Thu, 08/27/15 - 09:55 am
JNJ
daratumumab
Multiple Myeloma
Kyprolis
Amgen
Genmab
elotuzumab
AbbVie
Bristol-Myers Squibb
Dr. Reddy’s Announces Strategic Collaboration with Amgen in India
Yahoo
Thu, 08/6/15 - 10:21 am
Dr Reddy's
Amgen
India
Kyprolis
Blincyto
Repatha
Amgen wins new myeloma nod for blockbuster hopeful Kyprolis
Fierce Pharma
Mon, 07/27/15 - 01:46 pm
Amgen
Multiple Myeloma
Kyprolis
Celgene
Pomolyst
Amgen awaiting FDA decision on cancer drug Kyprolis
BioPharma Dive
Tue, 07/14/15 - 11:44 am
Amgen
FDA
Kyprolis
Multiple Myeloma
Amgen's Single Most Important FDA Decision of 2015 Is Nearly Here
Motley Fool
Thu, 07/9/15 - 07:46 pm
Amgen
FDA
Multiple Myeloma
Kyprolis
Amgen: The Quiet Winner
Barron's
Wed, 06/3/15 - 12:36 pm
Amgen
ASCO
Kyprolis
Amgen Hopes Kyprolis Can Become a Blockbuster
Investopedia
Thu, 04/2/15 - 11:31 am
Amgen
Kyprolis
Multiple Myeloma
Was Onyx worth it? Amgen's case is looking up as Kyprolis bests Velcade in head-to-head trial
Fierce Pharma
Tue, 03/3/15 - 08:05 am
ONYX Pharmaceuticals
Amgen
Velcade
Kyprolis
Multiple Myeloma
Amgen's Kyprolis Outperforms Rival Drug In Study
Forbes
Mon, 03/2/15 - 08:05 am
Amgen
Kyprolis
Velcade
Takeda
Multiple Myeloma
Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma
Yahoo/PR Newswire
Sat, 12/6/14 - 11:18 am
Amgen
ONYX Pharmaceuticals
Kyprolis
Multiple Myeloma
3 Reasons Amgen Inc.'s Stock Could Fall
Motley Fool
Tue, 08/26/14 - 10:00 am
Amgen
Kyprolis
Most Popular News Headlines For Thursday, August 14 2014
CP Wire
Fri, 08/15/14 - 06:19 am
FDA
Kyprolis
Amgen
asthma
AstraZeneca
AbbVie
orphan drugs
ABT-414
female se
Most popular news headlines for Thursday, August 14 2014
Fri, 08/15/14 - 06:18 am
FDA
Kyprolis
Amgen
asthma
AstraZeneca
AbbVie
orphan drugs
ABT-414
female se
Amgen: Why No One Cares About Kyprolis Trial Failure
Barron's
Fri, 08/15/14 - 05:21 am
Amgen
Kyprolis
Multiple Myeloma
Pages
« first
‹ previous
1
2
3
4
next ›
last »